1. Home
  2. ELUT vs STHO Comparison

ELUT vs STHO Comparison

Compare ELUT & STHO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ELUT
  • STHO
  • Stock Information
  • Founded
  • ELUT 2015
  • STHO N/A
  • Country
  • ELUT United States
  • STHO United States
  • Employees
  • ELUT N/A
  • STHO N/A
  • Industry
  • ELUT Medical Specialities
  • STHO Real Estate
  • Sector
  • ELUT Health Care
  • STHO Real Estate
  • Exchange
  • ELUT Nasdaq
  • STHO Nasdaq
  • Market Cap
  • ELUT 94.0M
  • STHO 89.7M
  • IPO Year
  • ELUT 2020
  • STHO N/A
  • Fundamental
  • Price
  • ELUT $2.08
  • STHO $6.53
  • Analyst Decision
  • ELUT Strong Buy
  • STHO
  • Analyst Count
  • ELUT 2
  • STHO 0
  • Target Price
  • ELUT $8.00
  • STHO N/A
  • AVG Volume (30 Days)
  • ELUT 38.7K
  • STHO 93.2K
  • Earning Date
  • ELUT 05-08-2025
  • STHO 05-20-2025
  • Dividend Yield
  • ELUT N/A
  • STHO N/A
  • EPS Growth
  • ELUT N/A
  • STHO N/A
  • EPS
  • ELUT N/A
  • STHO N/A
  • Revenue
  • ELUT $23,711,000.00
  • STHO $113,297,000.00
  • Revenue This Year
  • ELUT $39.35
  • STHO N/A
  • Revenue Next Year
  • ELUT $61.26
  • STHO N/A
  • P/E Ratio
  • ELUT N/A
  • STHO N/A
  • Revenue Growth
  • ELUT N/A
  • STHO N/A
  • 52 Week Low
  • ELUT $1.79
  • STHO $6.09
  • 52 Week High
  • ELUT $5.24
  • STHO $14.50
  • Technical
  • Relative Strength Index (RSI)
  • ELUT 43.18
  • STHO 42.45
  • Support Level
  • ELUT $1.79
  • STHO $6.11
  • Resistance Level
  • ELUT $2.44
  • STHO $7.02
  • Average True Range (ATR)
  • ELUT 0.22
  • STHO 0.35
  • MACD
  • ELUT 0.00
  • STHO 0.06
  • Stochastic Oscillator
  • ELUT 46.27
  • STHO 46.41

About ELUT Elutia Inc.

Elutia Inc Formerly Aziyo Biologics Inc is a commercial-stage regenerative medicine company focused on creating the next generation of differentiated products and improving outcomes in patients undergoing surgery, concentrating on patients receiving implantable medical devices. The company's segments include Device Protection, Women's Health and Cardiovascular. It generates maximum revenue from the Women's Health segment. The products of the company are targeted to address unmet clinical needs with the goal of promoting healthy tissue formation and avoiding complications associated with medical device implants, such as scar-tissue formation, capsular contraction, erosion, migration, non-union of implants and implant rejection.

About STHO Star Holdings Shares of Beneficial Interest

Star Holdings engages in non-ground lease-related businesses, including real estate finance, operating properties, and land and development. Its portfolio is comprised of its interests in Asbury and Magnolia Green residential development projects, a portfolio of commercial real estate properties, and loans that are being marketed for sale. The Company operates its business through one reportable and operating segment that focuses on realizing value for shareholders by generating cash flows through active asset management and sales of its existing loans, operating properties and land and development properties.

Share on Social Networks: